JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB203547

Recombinant Human Protein FAM19A5

Be the first to review this product! Submit a review

|

(0 Publication)

Recombinant Human Protein FAM19A5 is a Human Fragment protein, in the 26 to 125 aa range, expressed in Escherichia coli, with >95%, < 1 EU/µg endotoxin level, suitable for SDS-PAGE, ELISA, WB, Mass Spec.

View Alternative Names

FAM19A5, UNQ5208/PRO34524, TAFA5, Chemokine-like protein TAFA-5

1 Images
SDS-PAGE - Recombinant Human Protein FAM19A5 (AB203547)
  • SDS-PAGE

Supplier Data

SDS-PAGE - Recombinant Human Protein FAM19A5 (AB203547)

14% SDS-PAGE separation of ab203547.
1. M.W. marker – 14, 21, 31, 45, 66, 97 kDa
2. Reduced and heated sample, 2.5μg / lane
3. Non-reduced and non-heated sample, 2.5μg / lane

ab203547 migrates as two significant bands corresponding to molecular mass 10kDa and 14kDa, respectively. Both bands were confirmed by LC-MS/MS and identified as FAM19A5.

Key facts

Purity

>95% Densitometry

Endotoxin level

< 1 EU/µg

Expression system

Escherichia coli

Tags

His tag N-Terminus

Applications

ELISA, WB, Mass Spec, SDS-PAGE

applications

Biologically active

No

Accession

Q7Z5A7

Animal free

No

Carrier free

No

Species

Human

Storage buffer

pH: 7.5 Constituents: 10% Glycerol (glycerin, glycerine), 0.29% Sodium chloride, 0.24% Tris buffer

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "Mass Spec": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Sequence info

[{"sequence":"MKHHHHHHASQFLKEGQLAAGTCEIVTLDRDSSQPRRTIARQTARCACRKGQIAGTTRARPACVDARIIKTKQWCDMLPCLEGEGCDLLINRSGWTCTQPGGRIKTTTVS","proteinLength":"Fragment","predictedMolecularWeight":"12.2 kDa","actualMolecularWeight":null,"aminoAcidEnd":125,"aminoAcidStart":26,"nature":"Recombinant","expressionSystem":"Escherichia coli","accessionNumber":"Q7Z5A7","tags":[{"tag":"His","terminus":"N-Terminus"}]}]

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-80°C
Appropriate long-term storage conditions
-80°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
False

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The protein FAM19A5 also known as TAFA5 is a member of the TAFA family and plays a role in the regulation of nervous system function. It has an approximate mass of 13 kDa and exhibits expression primarily in the central nervous system including regions such as the brain. This protein is predominantly secreted as a small cytokine-like protein where it is involved in intercellular communication within the nervous tissue.
Biological function summary

The FAM19A5 protein influences neuroinflammatory processes and modulates the activity of neurons. While it does not form part of a large protein complex it may interact with extracellular matrix components to exert its effects. Its function is linked to the modulation of neural signaling indicating its role in maintaining homeostasis within the neural networks.

Pathways

This protein is known to engage with critical signaling cascades implicated in the central nervous system. In particular FAM19A5 is associated with the regulation of the chemokine signaling pathway. It is linked to pathways also involving proteins such as CCR5 and CXCR3 which interact in chemotaxis and influence neural cell responses. These pathways help in communicating signals that guide neural cell behavior affecting motor coordination and cognitive functions.

Current research suggests the involvement of FAM19A5 in conditions like neurodegenerative diseases and multiple sclerosis (MS). Its function in modulating neuroinflammation connects it to these disorders which involve immune responses that damage neural tissues. FAM19A5 may interact with other immune-related proteins like cytokines contributing to the pathophysiological processes observed in these diseases. The study of FAM19A5 provides insights into therapeutic targets for the management of such neurological disorders.

Specifications

Form

Liquid

General info

Function

Acts as a chemokine-like protein by regulating cell proliferation and migration through activation of G protein-coupled receptors (GPCRs), such as S1PR2 and FPR2 (By similarity). Stimulates chemotactic migration of macrophages mediated by the MAPK3/ERK1 and AKT1 pathway (By similarity). Blocks TNFSF11/RANKL-induced osteoclast formation from macrophages by inhibiting up-regulation of osteoclast fusogenic and differentiation genes (By similarity). Stimulation of macrophage migration and inhibition of osteoclast formation is mediated via GPCR FPR2 (By similarity). Acts as an adipokine by negatively regulating vascular smooth muscle cell (VSMC) proliferation and migration in response to platelet-derived growth factor stimulation via GPCR S1PR2 and G protein GNA12/GNA13-transmitted RHOA signaling (By similarity). Inhibits injury-induced cell proliferation and neointima formation in the femoral arteries (By similarity).

Sequence similarities

Belongs to the TAFA family.

Product protocols

Target data

Acts as a chemokine-like protein by regulating cell proliferation and migration through activation of G protein-coupled receptors (GPCRs), such as S1PR2 and FPR2 (By similarity). Stimulates chemotactic migration of macrophages mediated by the MAPK3/ERK1 and AKT1 pathway (By similarity). Blocks TNFSF11/RANKL-induced osteoclast formation from macrophages by inhibiting up-regulation of osteoclast fusogenic and differentiation genes (By similarity). Stimulation of macrophage migration and inhibition of osteoclast formation is mediated via GPCR FPR2 (By similarity). Acts as an adipokine by negatively regulating vascular smooth muscle cell (VSMC) proliferation and migration in response to platelet-derived growth factor stimulation via GPCR S1PR2 and G protein GNA12/GNA13-transmitted RHOA signaling (By similarity). Inhibits injury-induced cell proliferation and neointima formation in the femoral arteries (By similarity).
See full target information TAFA5

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com